MORGAN STANLEY

Holdings History for Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)

Symbol: ATXS
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$10,613,307	810,795	-53,610	-6.2%	$13.09	Q4 2025
30 Sep 2025	0%	+0%	$6,292,869	864,405	+338,853	+64%	$7.28	Q3 2025
30 Jun 2025	0%	+0%	$2,816,959	525,552	+325,527	+163%	$5.36	Q2 2025
31 Mar 2025	0%	+0%	$1,068,133	200,025	+47,869		$5.34	Q1 2025
31 Dec 2024	0%	-0%	$1,360,275	152,156	-77,555		$8.94	Q4 2024
30 Sep 2024	0%	+0%	$2,529,118	229,711	+119,051	+100%	$11.01	Q3 2024
30 Jun 2024	0%	-0%	$1,007,007	110,660	-114,895		$9.10	Q2 2024
31 Mar 2024	0%	-0%	$3,174,686	225,555	-151,983	-40%	$14.08	Q1 2024
31 Dec 2023	0%	+0%	$2,899,491	377,538	+344,188	+1032%	$7.68	Q4 2023
30 Sep 2023	0%	-0%	$248,790	33,350	-20,593	-38%	$7.46	Q3 2023
30 Jun 2023	0%	-0%	$449,344	53,943	-29,906	-36%	$8.33	Q2 2023
31 Mar 2023	0%	+0%	$1,115,192	83,849	+64,024	+323%	$13.30	Q1 2023
31 Dec 2022	0%	+0%	$295,196	19,825	+9,123	+85%	$14.89	Q4 2022
30 Sep 2022	0%	+0%	$97,000	10,702	+8,202	+328%	$9.06	Q3 2022
30 Jun 2022	0%	0%	$8,000	2,500	-500	-17%	$3.20	Q2 2022
31 Mar 2022	0%	0%	$20,000	3,000	0		$6.67	Q1 2022
31 Dec 2021	0%	0%	$16,000	3,000	0		$5.33	Q4 2021
30 Sep 2021	0%	+0%	$27,000	3,000	+3,000	NEW	$9.00	Q3 2021
30 Sep 2021		0%	$1,000	66	0		$15.15 ^*	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.